Mutation of mouse Mayp/Pstpip2 causes a macrophage autoinflammatory disease.
Macrophage actin-associated tyrosine phosphorylated protein (MAYP)/PSTPIP2, a PCH protein, is involved in the regulation of macrophage motility. Mutations in a closely related gene, PSTPIP1/CD2BP1, cause a dominantly inherited autoinflammatory disorder known as PAPA syndrome. A mutant mouse obtained by chemical mutagenesis exhibited an autoinflammatory disorder characterized by macrophage infiltration and inflammation, leading to osteolysis and necrosis in paws and necrosis of ears. Positional cloning of this recessive mutation, termed Lupo, identified a T to A nucleotide exchange leading to an amino acid substitution (I282N) in the sequence of MAYP. Mayp(Lp/Lp) disease was transferable by bone marrow transplantation and developed in the absence of lymphocytes. Consistent with the involvement of macrophages, lesion development could be prevented by the administration of clodronate liposomes. MAYP is expressed in monocytes/macrophages and in a Mac1+ subfraction of granulocytes. LPS stimulation increases its expression in macrophages. Because of the instability of the mutant protein, MAYP expression is reduced 3-fold in Mayp(Lp/Lp) macrophages and, on LPS stimulation, does not rise above the level of unstimulated wild-type (WT) cells. Mayp(Lp/Lp) mice expressed elevated circulating levels of several cytokines, including MCP-1; their macrophages exhibited altered cytokine production in vitro. These studies suggest that MAYP plays an anti-inflammatory role in macrophages.
Grosse
Johannes
J
Ingenium Pharmaceuticals, Martinsried, Germany.
Chitu
Violeta
V
Marquardt
Andreas
A
Hanke
Petra
P
Schmittwolf
Carolin
C
Zeitlmann
Lutz
L
Schropp
Patricia
P
Barth
Bettina
B
Yu
Philipp
P
Paffenholz
Rainer
R
Stumm
Gabriele
G
Nehls
Michael
M
Stanley
E Richard
ER
D048868:Adaptor Proteins, Signal Transducing / Q000235:genetics* / Q000378:metabolism; D019943:Amino Acid Substitution; D000818:Animals; D001327:Autoimmune Diseases / Q000188:drug therapy / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D050071:Bone Density Conservation Agents / Q000008:administration & dosage; D016026:Bone Marrow Transplantation / Q000379:methods; D002465:Cell Movement / Q000235:genetics*; D002478:Cells, Cultured; D004002:Clodronic Acid / Q000008:administration & dosage; D016207:Cytokines / Q000378:metabolism; D003598:Cytoskeletal Proteins / Q000235:genetics* / Q000378:metabolism; D005786:Gene Expression Regulation / Q000187:drug effects / Q000235:genetics; D005808:Genes, Recessive / Q000235:genetics; D006098:Granulocytes / Q000378:metabolism / Q000473:pathology; D007249:Inflammation / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D008070:Lipopolysaccharides / Q000494:pharmacology; D008214:Lymphocytes / Q000378:metabolism / Q000473:pathology; D016177:Macrophage-1 Antigen / Q000378:metabolism; D008264:Macrophages / Q000378:metabolism* / Q000473:pathology; D051379:Mice; D008817:Mice, Mutant Strains; D016296:Mutagenesis; D010014:Osteolysis / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D017354:Point Mutation; D013577:Syndrome
D048868:Adaptor Proteins, Signal Transducing; D050071:Bone Density Conservation Agents; D016207:Cytokines; D003598:Cytoskeletal Proteins; D008070:Lipopolysaccharides; D016177:Macrophage-1 Antigen; C110097:Pstpip1 protein, mouse; C486383:Pstpip2 protein, mouse; D004002:Clodronic Acid